How have TLSIW shares performed in 2024?

TriSalus Life Sciences' stock was trading at $1.19 at the beginning of the year. Since then, TLSIW stock has decreased by 21.0% and is now trading at $0.9405. View the best growth stocks for 2024 here .

Are investors shorting TriSalus Life Sciences?

TriSalus Life Sciences saw a decrease in short interest during the month of April. As of April 15th, there was short interest totaling 9,400 shares, a decrease of 15.3% from the March 31st total of 11,100 shares. Based on an average daily trading volume, of 7,300 shares, the days-to-cover ratio is presently 1.3 days. View TriSalus Life Sciences' Short Interest .

How do I buy shares of TriSalus Life Sciences?

Shares of TLSIW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:TLSIW

TriSalus Life Sciences (TLSIW) Stock Price, News & Analysis

→ Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad)

Free TLSIW Stock Alerts

$0.94

+0.04 (+4.50%)

(As of 11:10 AM ET)

Compare

Today's Range: $0.94
▼
$0.94
50-Day Range: $0.90
▼
$1.22
52-Week Range: $0.02
▼
$1.35

Volume: 204 shs
Average Volume: 10,977 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Financials Ownership SEC Filings Short Interest Social Media

Get TriSalus Life Sciences alerts:

Ad Stansberry Research

Biggest hedge fund manager has huge warning for U.S. dollar

Prescient CEO Makes Shocking New Prediction Known for his eerily accurate market calls over the years, this CEO has just revealed his newest prediction about "America's New Money."

Get the details before it's taken offline.

About TriSalus Life Sciences

TriSalus Life Sciences, Inc., a medical technology company, researches, develops, and sells drug delivery technologies and immune-oncology therapeutics for the treatment of liver and pancreatic cancer. The company offers Pressure Enabled Drug Delivery infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial, for locally advanced pancreatic cancer. It also develops nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma with liver metastases, hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and locally advanced pancreatic ductal adenocarcinoma. The company serves interventional radiologists, IR technicians, medical oncologists, nursing support, value analysis committee staff, and patients through its sales representatives and sales managers. TriSalus Life Sciences, Inc. was founded in 2009 and is headquartered in Westminster, Colorado.

TLSIW Stock Price History

30 days | 90 days | 365 days | Advanced Chart

TLSIW Stock News Headlines

April 1, 2024 | investorplace.com

TLSI Stock Earnings: TriSalus Life Sciences Misses EPS, Beats Revenue for Q4 2023

See More Headlines

Receive TLSIW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TriSalus Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Medical Devices
Sub-Industry: N/A
Current Symbol: NASDAQ:TLSIW
CUSIP: N/A
CIK: 1826667
Web: trisaluslifesci.com
Phone: 888-321-5212
Fax: N/A
Employees: 112
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: $18.51 million
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

Ms. Mary T. Szela B.S.N. (Age 60)
M.B.A., CEO, President & Director
Comp: $880.67k
Mr. Sean Edward Murphy (Age 71)
CFO & Director
Comp: $628.75k
Dr. Steven C. Katz F.A.C.S. (Age 49)
M.D., Chief Medical Officer & Chairman of Scientific Advisory Board
Comp: $849.89k
Ms. Lori Ann Santamaria
Vice President of Operations
Dr. Bryan F. Cox Ph.D. (Age 62)
Chief Scientific & Manufacturing Officer
Mr. James E. Young
Senior VP of Investor Relations & Treasurer
Ms. Rachel Garcia
Marketing Manager
Dr. Richard B. Marshak M.B.A. (Age 65)
MBA, VMD, Senior Vice President of Corporate Development & Strategy
Ms. Jennifer L. Stevens J.D. (Age 63)
Chief Regulatory Officer
Comp: $630k
Ms. Jodi Devlin (Age 62)
President of Commercial Operations

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

TLSIW Stock Analysis - Frequently Asked Questions

How have TLSIW shares performed in 2024?: TriSalus Life Sciences' stock was trading at $1.19 at the beginning of the year. Since then, TLSIW stock has decreased by 21.0% and is now trading at $0.9405.
View the best growth stocks for 2024 here.
Are investors shorting TriSalus Life Sciences?: TriSalus Life Sciences saw a decrease in short interest during the month of April. As of April 15th, there was short interest totaling 9,400 shares, a decrease of 15.3% from the March 31st total of 11,100 shares. Based on an average daily trading volume, of 7,300 shares, the days-to-cover ratio is presently 1.3 days.
View TriSalus Life Sciences' Short Interest.
How do I buy shares of TriSalus Life Sciences?: Shares of TLSIW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:TLSIW) was last updated on 5/10/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial